SEC Form 4 · accession 0001104659-17-035883
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary S Jacob
Officer — Chief Executive Officer · Director
Period of report
May 26, 2017
Accepted (ET)
May 30, 2017 · 7:55 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 26, 2017 | P | 5,680 | $3.5154 | A | 402,679 | D |
Table II — derivative securities
No Table II lines on this filing.